April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9); b) 60-count bottle (NDC 68788-9869-
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703,
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703,
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 6
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 6878
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 6
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27
Hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
April 12, 2023DrugsFDA
Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Ph
Hazard: Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
April 12, 2023DrugsFDA
Direct Rx recalls Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72
Hazard: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
April 12, 2023DrugsFDA
Direct Rx recalls Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx
Hazard: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
April 12, 2023DrugsFDA
Direct Rx recalls Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC
Hazard: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6)
Hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595
Hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
April 12, 2023DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenrid
Hazard: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
April 12, 2023DrugsFDA
RemedyRepack Inc. recalls Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count bottles (NDC 70518-0060-0
Hazard: cGMP Deviations
April 12, 2023DrugsFDA
RemedyRepack Inc. recalls Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-
Hazard: cGMP Deviations
April 12, 2023DrugsFDA
RemedyRepack Inc. recalls Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles
Hazard: cGMP Deviations
April 12, 2023DrugsFDA
RemedyRepack Inc. recalls Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519
Hazard: cGMP Deviations
April 12, 2023DrugsFDA
RemedyRepack Inc. recalls Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC
Hazard: cGMP Deviations
April 12, 2023DrugsFDA
RemedyRepack Inc. recalls Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-0
Hazard: cGMP Deviations